サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：再生創傷治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1303143

再生創傷治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年

Regenerative Wound Care Market-Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Wound Type, By End User, By Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 118 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

再生創傷治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

再生創傷治療の世界市場は、火傷、怪我、爛傷、潰瘍などによる創傷の発生率の増加によって牽引されています。

さらに、様々な種類の怪我や転倒の影響を受けやすい老人人口の増加が、再生創傷治療市場の需要を増加させると予想されます。高齢者人口では、他の様々な関連疾患のために創傷治癒プロセスが遅いため、創傷治癒を早める製品への需要が高まり、市場の成長を支えています。国連経済社会局人口部によると、65歳以上の高齢者数は2050年までに15億4,890万人に達すると予想されています。

糖尿病患者の増加

糖尿病の有病率の増加は、再生創傷治療の需要を増加させると予想されます。糖尿病は中国やインドを含むいくつかの発展途上国で大流行しています。糖尿病は創傷、特に感染症、慢性創傷、潰瘍の全体的な発生率と複雑性を高める可能性があります。そのため治療が必要となり、法外な医療費がかかります。世界保健機関（WHO）の報告によると、2019年の死亡原因の74％は非伝染性疾患であり、糖尿病では160万人が死亡し、世界第9位の死因となっています。世界的にも、インドのような新興国でも、糖尿病の負担は大きく、主に過体重／肥満の割合の上昇と不健康な生活習慣が原因で増加しています。異常に高い血糖値など数多くの要因が、血管や神経を傷つける可能性があります。そのため、手足への血流が悪くなり、切り傷やただれが治りにくくなります。米国疾病予防管理センター（CDC）の推計によると、米国では人口の11.3％にあたる約3,730万人が糖尿病を患っています。糖尿病はまた、創傷治癒に影響を及ぼす糖尿病性神経障害を引き起こす可能性があります。

火傷、事故、怪我の増加

手術、事故、怪我などによる創傷の増加により、再生創傷治療の需要が大幅に増加しています。世界的に死因の第10位は交通事故であり、スピード違反、アルコールやその他の精神作用物質の影響下での運転、オートバイ用ヘルメット、シートベルト、チャイルドシートの不使用、脇見運転、安全でない車両、事故後の不十分なケア、交通法規の不十分な施行など、いくつかの要因によって最も多く発生しています。WHOの推定によると、毎年交通事故によって130万人以上の命が奪われています。さらに2,000万人から5,000万人が致命的でない負傷を負い、その多くが結果として身体障害者となっています。

最近の動向

世界の再生創傷治療市場は、競争力を維持し、市場で事業を展開するその他のプレーヤーよりも優位に立つために、M&A、新製品の発売、新たな臨床試験の開始、研究開発活動の増加、投資などの形で多くの新たな展開を目の当たりにしています。

  • 2021年6月、MiMedx Group, Inc.は、厚生労働省から同社の製品であるEpifixの日本における商業化の承認を取得しました。
  • 2019年5月、Organogenesis Inc.はVizient, Inc.と契約を締結しました。これにより、オルガノジェネシスは創傷ケア製品の提供を増やし、市場でのポジショニングを向上させました。

利用可能なカスタマイズ

TechSciリサーチは、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 調査対象年
    • 主要市場セグメンテーション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 臨床試験分析

第6章 再生創傷治療の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（自己幹細胞、生体皮膚代替物、組織/複数組織プラットフォーム、胎児皮膚、再生創傷治療デバイス、その他）
    • 創傷タイプ別（潰瘍、外科的・外傷性創傷、熱傷）
    • エンドユーザー別（病院、外来手術センター、熱傷治療センター・創傷クリニック、その他）
    • 地域別
    • 企業別（2022年）
  • 市場マップ

第7章 北米の再生創傷治療市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州の再生創傷治療市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋の再生創傷治療市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の再生創傷治療市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの再生創傷治療市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

  • 最近の動向
  • 合併・買収
  • 製品発表

第14章 競合情勢

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials（As Reported）
  • Recent Developments
  • SWOT Analysis
    • DeCell Technologies Inc.
    • Avita Medical, Inc.
    • Organogenesis, Inc.
    • Histogen, Inc.
    • RenovoDerm（Nanofiber Solutions, LLC）
    • StemsysBio
    • Koninklijke DSM N.V.
    • MiMedx Group, Inc.

第15章 戦略的提言

目次
Product Code: 14405

Global Regenerative Wound Care Market is driven by the growing incidence of wounds caused due to burns, injuries, soars & ulcers, among others. Additionally, a growing geriatric population that is susceptible to various kinds of injuries and falls is expected to increase the demand for the regenerative wound care market. In the elderly population, due to various other associated conditions, the wound healing process is slow, leading to the demand for products that can bring about faster wound healing, thereby supporting market growth. According to the United Nations Department of Economic and Social Affairs, Population Division, the number of persons aged 65 years or above is expected to reach 1548.9 million by 2050.

The growing number of surgical procedures performed, along with increasing incidences of chronic burns, is further expected to increase the demand for the regenerative wound care market. Furthermore, the growing prevalence of diabetes is expected to fuel market growth in the coming years. Moreover, increasing research & development and new product approvals & launches are further expected to create lucrative opportunities for market growth. According to clinicaltrials.gov, as of 12th December, there are around 57 clinical trials registered across the globe related to regenerative wound care, which is in different phases of development worldwide. This, in turn, has led to the development and launch of new products. Organogenesis, Inc. was the first company to receive FDA approvals for a living, human cell-based product, Apligraf, and Dermagraft.

Apligraf is bioengineered with living cells that are bioactive to transform wounds from chronic to acute. Apligraf has illustrated clinical evidence in the treatment of Healing Venous Leg Ulcers and Diabetic Foot Ulcers. Apligraf resembles and functions like healthy human skin. Similarly, Dermagraft is a sterile, cryopreserved, human fibroblast-derived dermal substitute generated by the culture of neonatal dermal fibroblasts onto a bioabsorbable polyglactin mesh scaffold for the treatment of Diabetic Foot Ulcer in the United States.

Increasing cases of diabetes

The growing prevalence of diabetes is expected to increase the demand for regenerative wound care. Diabetes has become a pandemic in several developing nations, including China and India. Diabetes can increase the overall incidence and complexity of wounds, especially infections, chronic wounds, and ulcerations. This requires treatment and incurs exorbitant medical expenses. The World Health Organization (WHO) reports that non-communicable diseases caused 74% of deaths in 2019; diabetes killed 1.6 million people, making it the ninth largest cause of death worldwide. Globally and in emerging nations like India, the burden of diabetes is large and rising, primarily due to rising rates of overweight/obesity and unhealthy lifestyles. Numerous factors, such as abnormally high blood sugar, might damage blood vessels and nerves. This reduces blood flow to the hands, feet, and legs, which makes it more difficult for cuts and sores to heal. The Centers for Disease Control and Prevention (CDC) estimates that about 37.3 million people in the United States, or 11.3% of the population, have diabetes. Diabetes can also cause diabetic neuropathy, which can affect wound healing.

Increase in Incidences of Burns, Accidents, Injuries

The growing incidences of wounds caused due to surgeries, accidents, and injuries, among others, have significantly increased the demand for regenerative wound care. The tenth biggest cause of death globally is road traffic accidents, which are also the most common due to several factors such as speeding; driving under the influence of alcohol and other psychoactive substances; no-use of motorcycle helmets, seatbelts, and child restraints; distracted driving; unsafe vehicle; inadequate post-crash care and inadequate law enforcement of traffic laws. The WHO estimates that every year road traffic accidents claim the lives of over 1.3 million people. Between 20 and 50 million additional people have non-fatal injuries, with many of them becoming disabled as a result.

Market Segmentation

Global Regenerative Wound Care Market can be segmented by type, by wound type, by end-user, and by region. Based on type, the market can be categorized into autologous stem cells, biological skin substitutes, tissue/multiple tissue platforms, fetal skin, regenerative wound care devices, and others. Based on wound type, the market can be fragmented into ulcers, surgical & traumatic wounds, and burns. Ulcers can further be divided into diabetic foot ulcers, pressure ulcers, and others. Based on end-user, the market can be grouped into hospitals, ambulatory surgical centers, burn care centers & wound clinics, and others. Regionally, the market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

DeCell Technologies Inc., Avita Medical, Inc., Organogenesis, Inc., Histogen, Inc., RenovoDerm (Nanofiber Solutions, LLC), StemsysBio, Koninklijke DSM N.V., MiMedx Group, Inc., among others, are some of the leading players operating in the global regenerative wound care market.

Recent Developments

Global Regenerative Wound Care Market is witnessing a lot of new developments in the form of mergers & acquisitions, new product launches, launching new clinical trials, increasing research & development activities, and making investments, among others, in order to stay competitive and an edge over the other players operating in the market.

  • In June 2021, MiMedx Group, Inc. received approval for the commercialization of its product Epifix in Japan from the Japanese Ministry of Health, Labour, and Welfare.
  • In May 2019, Organogenesis Inc. entered into an agreement with Vizient, Inc. This, in turn, helped Organogenesis increase its wound care product offerings and improve its market positioning.

Report Scope

In this report, Global Regenerative Wound Care Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Regenerative Wound Care Market, By type:

  • Autologous Stem Cells
  • Biological Skin Substitutes
  • Tissue/Multiple Tissue Platform
  • Fetal Skin
  • Regenerative Wound Care Devices
  • Others

Regenerative Wound Care Market, By Wound Type:

  • Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Others
  • Surgical & Traumatic Wounds
  • Burns

Regenerative Wound Care Market, By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Burn Care Centers & Wound Clinics
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Regenerative Wound Care Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Regenerative Wound Care Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 6.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 6.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 6.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Market Map

7. North America Regenerative Wound Care Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 7.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 7.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 7.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Regenerative Wound Care Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Regenerative Wound Care Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Regenerative Wound Care Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By End User

8. Europe Regenerative Wound Care Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. B By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 8.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 8.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 8.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Regenerative Wound Care Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Regenerative Wound Care Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Regenerative Wound Care Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Regenerative Wound Care Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Regenerative Wound Care Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By End User

9. Asia-Pacific Regenerative Wound Care Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 9.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 9.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 9.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Regenerative Wound Care Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By End User
    • 9.3.2. India Regenerative Wound Care Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Regenerative Wound Care Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Regenerative Wound Care Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Wound Type
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Regenerative Wound Care Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Wound Type
        • 9.3.5.2.3. By End User

10. South America Regenerative Wound Care Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 10.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 10.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 10.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Regenerative Wound Care Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Regenerative Wound Care Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Regenerative Wound Care Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By End User

11. Middle East and Africa Regenerative Wound Care Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 11.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 11.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 11.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Regenerative Wound Care Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Wound Type
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Regenerative Wound Care Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Wound Type
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Regenerative Wound Care Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Wound Type
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (As Reported)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. DeCell Technologies Inc.
    • 14.6.2. Avita Medical, Inc.
    • 14.6.3. Organogenesis, Inc.
    • 14.6.4. Histogen, Inc.
    • 14.6.5. RenovoDerm (Nanofiber Solutions, LLC)
    • 14.6.6. StemsysBio
    • 14.6.7. Koninklijke DSM N.V.
    • 14.6.8. MiMedx Group, Inc.

15. Strategic Recommendations